Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma"
J Hepatol. 2017 Jun;66(6):1334-1335.
doi: 10.1016/j.jhep.2017.02.021.
Epub 2017 Mar 13.
1 National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Molecular Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
2 National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
3 Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan.
4 Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
5 Industrial Technology Research Institute, Hsin-Chu, Taiwan.
6 Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: peijerchen@ntu.edu.tw.
7 Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: kfchen1970@ntu.edu.tw.